AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25881576
Drug: Higher intensity
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher intensity CRRT (40 mL/kg per hour)
Trial: 25881576
Drug: Lower intensity
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower intensity CRRT (25 mL/kg per hour)
Trial: 19900941
Drug: Single-dose cruciferous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose cruciferous diet
Trial: 19900941
Drug: Double-dose cruciferous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose cruciferous diet
Trial: 15566625
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (6 g per day containing 1.5 g DHA)
Trial: 15566625
Drug: Placebo (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (6 g per day of olive oil)
Trial: 11678781
Drug: Artesunate 100
RxNorm normalized name: Artesunate 100 mg rectal suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artesunate 100 mg on days -5, 1, and 5; artemisinin 500 mg on days 1 and 5.
Trial: 11678781
Drug: Artemisinin 500
RxNorm normalized name: ARTEMISININ
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemisinin 500 mg on days -5, 1, and 5; artesunate 100 mg on days 1 and 5.
Trial: 9577289
Drug: Ranitidine 0.5
RxNorm normalized name: ranitidine 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 0.5 mg/kg body weight twice a day for preterm infants
Trial: 9577289
Drug: Ranitidine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 1.5 mg/kg body weight three times a day for term infants
Trial: 3276111
Drug: Calcium heparin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium heparin, 12,500 IU by the subcutaneous route
Trial: 3276111
Drug: Placebo by
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo by the intramuscular route
Trial: 26887879
Drug: Portable domestic
RxNorm normalized name: domestic cow dander extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Portable domestic pelvic floor neuromuscular electrical stimulation for 12 weeks after 4 weeks of hospital treatment
Trial: 26887879
Drug: Pelvic floor
RxNorm normalized name: Tenscare Kegel Toner Pelvic Floor Trainer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic floor electrophysiological treatment in hospital for 4 weeks
Trial: 19107187
Drug: Visual training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Visual training with six highly similar bird types; specific details on dosage and duration not available.
Trial: 19107187
Drug: Visual training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Visual training with similar birds without established category-boundaries; specific details on dosage and duration not available.
Trial: 15357562
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration (IV group, n = 25): ketamine 1 mg/kg and midazolam 0.05-0.1 mg/kg
Trial: 15357562
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration (PO group, n = 24): ketamine 3 mg/kg and midazolam 0.5 mg/kg
Trial: 15357562
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration (PR group, n = 24): ketamine 3 mg/kg and midazolam 0.5 mg/kg
Trial: 1443450
Drug: terfenadine 60
RxNorm normalized name: terfenadine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine 60 mg daily
Trial: 1443450
Drug: terfenadine 120
RxNorm normalized name: terfenadine 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine 120 mg daily
Trial: 1443450
Drug: terfenadine 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine 180 mg daily
Trial: 1443450
Drug: terfenadine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine (all doses)
Trial: 29090982
Drug: High-Dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Dose (HD) influenza vaccine (Fluzone® High-Dose)
Trial: 29090982
Drug: Standard-Dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-Dose (SD) influenza vaccine (Fluzone®)
Trial: 20042925
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and IV combined rehydration
Trial: 20042925
Drug: All trials
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All trials (IV, oral, oral and IV combined, ad libitum)
Trial: 18005804
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy for 45 minutes
Trial: 10687110
Drug: Paroxetine 20
RxNorm normalized name: PARoxetine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20 mg once a day
Trial: 8758156
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 0.5 mg
Trial: 1837744
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment with 1600 micrograms salbutamol or 160 micrograms ipratropium bromide daily
Trial: 1837744
Drug: On demand
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On demand treatment with salbutamol or ipratropium bromide during exacerbations or periods of dyspnoea
Trial: 7619569
Drug: On demand
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On demand treatment
Trial: 6785100
Drug: Indomethacin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (75 mg/day for 3 days)
Trial: 29218366
Drug: Haploidentical donor
RxNorm normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haploidentical donor natural killer (NK) cell therapy with rituximab and IL‐2 (NK dose 0.5‐3.27 × 107 NK cells/kg)
Trial: 29218366
Drug: Haploidentical donor
RxNorm normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haploidentical donor natural killer (NK) cell therapy
Trial: 23402476
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg) / Hydrochlorothiazide (HCTZ, 12.5 mg)
Trial: 23402476
Drug: ARB +
RxNorm normalized name: revakinagene taroretcel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARB + Calcium Channel Blocker (CCB)
Trial: 17920723
Drug: Thalidomide 100mg
RxNorm normalized name: THALIDOMIDE 100MG CAP
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide 100mg orally daily with carboplatin and etoposide every 3 weeks for 6 cycles, followed by maintenance thalidomide for up to 2 years
Trial: 7027891
Drug: Metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 200 mg Durules once daily
Trial: 7027891
Drug: Metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 200 mg conventional tablets
Trial: 17984409
Drug: Sustained-release bupropion
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release bupropion hydrochloride, 150 mg/d
Trial: 17984409
Drug: Sustained-release bupropion
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release bupropion hydrochloride, 300 mg/d
Trial: 7788825
Drug: Intranasal meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal meperidine (nasal group) - 27 mg per dose, self-administered, up to six puffs, with a minimum delay of 10 minutes between doses.
Trial: 7788825
Drug: Subcutaneous meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous meperidine injections (sc group) - 25 or 50 mg on request.
Trial: 2082312
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg and 90 mg
Trial: 19178487
Drug: ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ingenol mebutate gel, 0.05%
Trial: 19178487
Drug: vehicle gel
RxNorm normalized name: vehicle gel base no.61
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vehicle gel
Trial: 8124991
Drug: Triazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.5 mg orally)
Trial: 8124991
Drug: Meperidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine (1 mg/kg, subcutaneously)
Trial: 60570
Drug: Cotrimoxazole (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotrimoxazole (4 tablets daily for 6-14 days)
Trial: 60570
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antibacterial therapy)
Trial: 31642726
Drug: Strength training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strength training program (10-minute program, 3 times weekly for 12 weeks) targeting quadriceps, hip abductor, and core muscle groups
Trial: 29945625
Drug: GSH+L-citrulline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSH+L-citrulline
Trial: 29945625
Drug: L-citrulline-malate
RxNorm normalized name: citrulline malate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-citrulline-malate
Trial: 24075613
Drug: PRGF-Endoret (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRGF-Endoret (3 injections on a weekly basis)
Trial: 24075613
Drug: Durolane hyaluronic
RxNorm normalized name: hyaluronate Prefilled Syringe [Durolane]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Durolane hyaluronic acid (1 single injection)
Trial: 18243430
Drug: Mw vaccine
RxNorm normalized name: polyethyloxazoline (200000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mw vaccine (1st dose of 1x10(9) heat killed organisms, 2nd dose of 5x10(8) organisms after 6 months)
Trial: 18243430
Drug: Mw vaccine
RxNorm normalized name: polyethyloxazoline (200000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mw vaccine
Trial: 18243430
Drug: Mw vaccine
RxNorm normalized name: polyethyloxazoline (200000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mw vaccine with BCG scars
Trial: 8952816
Drug: Intravenous linsidomine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous linsidomine 10 mg
Trial: 8952816
Drug: Parenteral isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral isosorbide dinitrate
Trial: 31473130
Drug: Oral TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral TXA regimen
Trial: 31473130
Drug: Combined topical/IV/oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined topical/IV/oral TXA
Trial: 29972742
Drug: Tecovirimat 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tecovirimat 600 mg twice daily for 14 days
Trial: 29972742
Drug: Tecovirimat 10
RxNorm normalized name: tecovirimat 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tecovirimat 10 mg/kg for 14 days (monkeypox model)
Trial: 29972742
Drug: Tecovirimat 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tecovirimat 40 mg/kg for 14 days (rabbitpox model)
Trial: 25609006
Drug: Cisplatin plus
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin plus bevacizumab (cisplatin: 40 mg/m2, bevacizumab: 300 mg, every 2 weeks for 6 weeks)
Trial: 25609006
Drug: Cisplatin only
RxNorm normalized name: Cisplatin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin only (control group, n=27, cisplatin: 40 mg/m2 every 2 weeks for 6 weeks)
Trial: 21906813
Drug: Ahmed‐FP7 valve
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ahmed‐FP7 valve implant
Trial: 21889801
Drug: Baerveldt‐350 implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baerveldt‐350 implant
Trial: 17217210
Drug: Benzocaine 18%
RxNorm normalized name: BENZALKONIUM CL 0.2/BENZOCAINE 18% LIQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzocaine 18% gel
Trial: 17217210
Drug: Lignocaine 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 5% ointment
Trial: 14624816
Drug: 7% carbon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7% carbon dioxide (CO2) gas inhalation
Trial: 3627711
Drug: Infants over
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infants over 1000 g birthweight in SC group
Trial: 25406953
Drug: Topical insulin-like
RxNorm normalized name: insulin-like growth factor 2
DrugBank: Insulin-like growth factor II (DB14472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical insulin-like growth factor-1 (IGF-1) therapy
Trial: 25406953
Drug: Intratympanic corticosteroid
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic corticosteroid therapy (Dexamethasone)
Trial: 22716204
Drug: metformin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metformin (3 g daily)
Trial: 18050189
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) plus intravenous methylprednisolone (IV MP)
Trial: 16085528
Drug: Contingency management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contingency management (CM; payment for chewing at least 12 pieces/day on 10 of 15 intervention days, n = 34) plus standard treatment (ST) and brief feedback (BF)
Trial: 16085528
Drug: Brief feedback
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief feedback (BF; n = 32) plus standard treatment (ST)
Trial: 16085528
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (ST; n = 31)
Trial: 12173710
Drug: Intravenous glutathione
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glutathione twice a day for 5 days
Trial: 12173710
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution twice a day for 5 days
Trial: 10226978
Drug: Theophylline (300-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (300-500 mg orally at night for 4-22 weeks)
Trial: 10226978
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nCPAP therapy)
Trial: 8767921
Drug: nitroglycerine-patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nitroglycerine-patches
Trial: 1505149
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg diazepam
Trial: 31349876
Drug: Secukinumab (anti-IL-17A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab (anti-IL-17A antibody) administered over 24 weeks
Trial: 25231697
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor (PPI) therapy for 6 months
Trial: 18095198
Drug: Fentanyl (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.7 microg/kg loading, 10 microg bolus dose with 5 minutes lockout time)
Trial: 18095198
Drug: Remifentanil (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (0.3 microg/kg loading, 20 microg bolus dose with 3 minutes lockout time)
Trial: 18095198
Drug: Control (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (saline solution without analgesic)
Trial: 16001776
Drug: Angiotensin converting
RxNorm normalized name: Angiotensin converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, and beta‐adrenergic blockers
Trial: 15071276
Drug: Prophylactic implantable
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic implantable cardioverter defibrillator (ICD) therapy
Trial: 9925529
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of mefloquine (25 mg/kg) on day 2 with food
Trial: 9925529
Drug: Split dose
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split dose of mefloquine (15 mg/kg on day 2 and 10 mg/kg on day 3) with food
Trial: 9925529
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of mefloquine (25 mg/kg) on day 0 without food
Trial: 9925529
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of mefloquine (25 mg/kg) on day 2 without food
Trial: 7789044
Drug: Intraperitoneal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal insulin delivery
Trial: 6236952
Drug: Desogestrel 0.125
RxNorm normalized name: desogestrel 0.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel 0.125 mg
Trial: 6236952
Drug: Desogestrel 0.250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel 0.250 mg
Trial: 6236952
Drug: Desogestrel 0.500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel 0.500 mg
Trial: 6236952
Drug: Lynestrenol 5
RxNorm normalized name: lynestrenol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lynestrenol 5 mg
Trial: 30232658
Drug: Vasopressin–Steroids–Epinephrine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasopressin–Steroids–Epinephrine combination
Trial: 23836299
Drug: Rehabilitation programme
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation programme including exercises and cognitive-behavioural therapy
Trial: 12153599
Drug: Oestrogen plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen plus methyltestosterone (1.25 mg esterified oestrogen and 2.5 mg methyltestosterone)
Trial: 12153599
Drug: Oestrogen only
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen only (1.25 mg esterified oestrogen)
Trial: 2145499
Drug: 5% tea-tree
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% tea-tree oil gel
Trial: 28431003
Drug: High-dose BMCs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose BMCs (hiBMCs)
Trial: 28431003
Drug: Low-dose BMCs
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose BMCs (loBMCs)
Trial: 28431003
Drug: Irradiated high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irradiated high-dose BMCs (irradiated hiBMCs)
Trial: 28431003
Drug: Irradiated low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Irradiated low-dose BMCs (irradiated loBMCs)
Trial: 15047458
Drug: No anti-anaemic
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anti-anaemic treatment
Trial: 18353329
Drug: GnRHa treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRHa treatment
Trial: 8770484
Drug: Anesthesia infusion
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthesia infusion sleeve (AIS)
Trial: 2894215
Drug: Ketanserin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (mean daily dose 71 mg)
Trial: 18677023
Drug: Subcutaneous growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous growth hormone (GH) starting dose 2 microg/kg/d, increased to maximum dose of 6 microg/kg/d for 18 months.
Trial: 15933559
Drug: Didanosine (ddI)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (ddI) 50 mg/m for infants >28 days of age
Trial: 15933559
Drug: Didanosine (ddI)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (ddI) 25 mg/m for infants < or =28 days of age, escalated to 50 mg/m
Trial: 9495218
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) treatment
Trial: 15933559
Drug: Didanosine (ddI)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (ddI) treatment
Trial: 10392222
Drug: Instillation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instillation of 5 mL of normal saline before endotracheal suctioning
Trial: 8546551
Drug: Sulfamethoxazole-trimethoprim (double-strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfamethoxazole-trimethoprim (double-strength tablet three times a week)
Trial: 8546551
Drug: Aerosolized pentamidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized pentamidine (dose not specified)
Trial: 8546551
Drug: Oral regimens
RxNorm normalized name: aspirin Oral Tablet [Anacin Aspirin Regimen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral regimens (compared to aerosolized pentamidine)
Trial: 28600725
Drug: Oxycodone DETERx
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone DETERx
Trial: 26923083
Drug: Quinvaxem in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinvaxem in cPAD injection system
Trial: 26923083
Drug: Quinvaxem in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinvaxem in single-dose vial
Trial: 26923083
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (cPAD and single-dose vial)